111. Organizational aspect in healthcare decision-making: a literature review. Issue 1 (1st January 2020) Authors: Dubromel, Amélie; Duvinage-Vonesch, Marie-Audrey; Geffroy, Loïc; Dussart, Claude Journal: Journal of market access & health policy Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
112. Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries. Issue 1 (1st January 2020) Authors: Jørgensen, Jesper; Hanna, Eve; Kefalas, Panos Journal: Journal of market access & health policy Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
113. Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region. Issue 1 (1st January 2017) Authors: Kaló, Zoltán; Vokó, Zoltán; Östör, Andrew; Clifton-Brown, Emma; Vasilescu, Radu; Battersby, Alysia; Gibson, Edward Journal: Journal of market access & health policy Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
114. Patient-reported outcome claims in European and United States orphan drug approvals. Issue 1 (1st January 2018) Authors: Jarosławski, Szymon; Auquier, Pascal; Borissov, Borislav; Dussart, Claude; Toumi, Mondher Journal: Journal of market access & health policy Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
115. Perceptions and factors affecting pharmaceutical market access: results from a literature review and survey of stakeholders in different settings. Issue 1 (1st January 2016) Authors: Sendyona, Semukaya; Odeyemi, Isaac; Maman, Khaled Journal: Journal of market access & health policy Issue: Volume 4:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
116. Perspectives to mitigate payer uncertainty in health technology assessment of novel oncology drugs. Issue 1 (1st January 2019) Authors: Solà-Morales, Oriol; Volmer, Timm; Mantovani, Lorenzo Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
117. Policy implementation for methicillin-resistant Staphylococcus aureus in seven European countries: a comparative analysis from 1999 to 2015. Issue 1 (1st January 2017) Authors: Kinoshita, Takuya; Tokumasu, Hironobu; Tanaka, Shiro; Kramer, Axel; Kawakami, Koji Journal: Journal of market access & health policy Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
118. President Trump's prescription to reduce drug prices: from the campaign trail to American Patients First. Issue 1 (1st January 2019) Authors: Dabbous, Monique; François, Clément; Chachoua, Lylia; Toumi, Mondher Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
119. Pricing of orphan drugs in oncology and rare diseases. Issue 1 (1st January 2020) Authors: Nuijten, Mark; Capri, Stefano Journal: Journal of market access & health policy Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
120. Pricing Zolgensma – the world's most expensive drug. Issue 1 (31st December 2022) Authors: Nuijten, Mark Journal: Journal of market access & health policy Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗